Published in Proc Natl Acad Sci U S A on July 05, 2007
Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev (2010) 1.76
Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun (2012) 1.66
Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery. Nat Med (2012) 1.53
Electrospun nanofibers for regenerative medicine. Adv Healthc Mater (2011) 1.44
Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J Surg Res (2008) 1.28
Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future. Stem Cells Transl Med (2012) 1.26
Pericyte-based human tissue engineered vascular grafts. Biomaterials (2010) 1.25
A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater (2009) 1.20
Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev (2010) 1.20
Biomaterials for vascular tissue engineering. Regen Med (2010) 1.19
The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs (2011) 1.15
In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A (2010) 1.14
Antithrombogenic modification of small-diameter microfibrous vascular grafts. Arterioscler Thromb Vasc Biol (2010) 1.12
Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease. Stem Cells Dev (2010) 1.09
Mesenchymal stem cells for vascular regeneration. Regen Med (2008) 1.06
The effect of fiber alignment and heparin coating on cell infiltration into nanofibrous PLLA scaffolds. Biomaterials (2010) 1.05
A small diameter, fibrous vascular conduit generated from a poly(ester urethane)urea and phospholipid polymer blend. Biomaterials (2009) 1.05
Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials (2010) 1.03
Engineered vascular tissue fabricated from aggregated smooth muscle cells. Cells Tissues Organs (2011) 0.99
Automated and adaptable quantification of cellular alignment from microscopic images for tissue engineering applications. Tissue Eng Part C Methods (2011) 0.97
Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med (2009) 0.95
Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications. Stem Cells Int (2016) 0.95
A novel flow bioreactor for in vitro microvascularization. Tissue Eng Part C Methods (2010) 0.94
The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration. Biomaterials (2012) 0.93
Proteomic Profiling of Mesenchymal Stem Cell Responses to Mechanical Strain and TGF-beta1. Cell Mol Bioeng (2009) 0.93
Acellular vascular grafts generated from collagen and elastin analogs. Acta Biomater (2013) 0.92
Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng Part B Rev (2012) 0.91
Regulation of the matrix microenvironment for stem cell engineering and regenerative medicine. Ann Biomed Eng (2011) 0.90
Animal models for vascular tissue-engineering. Curr Opin Biotechnol (2013) 0.89
Femtosecond laser ablation enhances cell infiltration into three-dimensional electrospun scaffolds. Acta Biomater (2012) 0.89
Blood outgrowth endothelial cells alter remodeling of completely biological engineered grafts implanted into the sheep femoral artery. J Cardiovasc Transl Res (2014) 0.87
The effect of pulsatile loading and scaffold structure for the generation of a medial equivalent tissue engineered vascular graft. Biores Open Access (2013) 0.86
Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity. Diabetes (2013) 0.85
Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair. J Control Release (2012) 0.85
Roles of bone-marrow-derived cells and inflammatory cytokines in neointimal hyperplasia after vascular injury. Biomed Res Int (2014) 0.84
Long-term viability of coronary artery smooth muscle cells on poly(L-lactide-co-epsilon-caprolactone) nanofibrous scaffold indicates its potential for blood vessel tissue engineering. J R Soc Interface (2008) 0.84
Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges. Cardiovasc Eng Technol (2011) 0.83
Vascular endoluminal delivery of mesenchymal stem cells using acoustic radiation force. Tissue Eng Part A (2011) 0.83
Rational design of nanofiber scaffolds for orthopedic tissue repair and regeneration. Nanomedicine (Lond) (2013) 0.83
Nerve regeneration and elastin formation within poly(glycerol sebacate)-based synthetic arterial grafts one-year post-implantation in a rat model. Biomaterials (2013) 0.82
A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes. J Cell Mol Med (2010) 0.80
PLLA-PEG-TCH-labeled bioactive molecule nanofibers for tissue engineering. Int J Nanomedicine (2011) 0.80
Synergism of matrix stiffness and vascular endothelial growth factor on mesenchymal stem cells for vascular endothelial regeneration. Tissue Eng Part A (2014) 0.80
Nanofibrous Patches for Spinal Cord Regeneration. Adv Funct Mater (2010) 0.80
Heart Valve Replacements with Regenerative Capacity. Transfus Med Hemother (2016) 0.80
Small-diameter tissue engineered vascular graft made of electrospun PCL/lecithin blend. J Mater Sci Mater Med (2012) 0.79
A cautionary tale for autologous vascular tissue engineering: impact of human demographics on the ability of adipose-derived mesenchymal stem cells to recruit and differentiate into smooth muscle cells. Tissue Eng Part A (2014) 0.79
Smooth muscle and other cell sources for human blood vessel engineering. Cells Tissues Organs (2011) 0.79
Two-stage implantation of the skin- and bone-integrated pylon seeded with autologous fibroblasts induced into osteoblast differentiation for direct skeletal attachment of limb prostheses. J Biomed Mater Res A (2013) 0.79
The Tissue-Engineered Vascular Graft-Past, Present, and Future. Tissue Eng Part B Rev (2015) 0.79
In Vivo Functional Evaluation of Tissue-Engineered Vascular Grafts Fabricated Using Human Adipose-Derived Stem Cells from High Cardiovascular Risk Populations. Tissue Eng Part A (2016) 0.79
Preliminary In Vivo Evaluation of a Hybrid Armored Vascular Graft Combining Electrospinning and Additive Manufacturing Techniques. Drug Target Insights (2016) 0.78
Response of mesenchymal stem cells to shear stress in tissue-engineered vascular grafts. Acta Pharmacol Sin (2009) 0.78
Advances in nanotechnology for the management of coronary artery disease. Trends Cardiovasc Med (2012) 0.78
Resilin-PEG Hybrid Hydrogels Yield Degradable Elastomeric Scaffolds with Heterogeneous Microstructure. Biomacromolecules (2015) 0.77
The fusion of tissue spheroids attached to pre-stretched electrospun polyurethane scaffolds. J Tissue Eng (2014) 0.77
Electrospinning covalently cross-linking biocompatible hydrogelators. Polymer (Guildf) (2012) 0.77
How to make a heart valve: from embryonic development to bioengineering of living valve substitutes. Cold Spring Harb Perspect Med (2014) 0.77
Patient-specific cardiovascular progenitor cells derived from integration-free induced pluripotent stem cells for vascular tissue regeneration. Biomaterials (2015) 0.76
Pericyte Seeded Dual Peptide Scaffold with Improved Endothelialization for Vascular Graft Tissue Engineering. Adv Healthc Mater (2016) 0.76
Mucin covalently bonded to microfibers improves the patency of vascular grafts. Tissue Eng Part A (2013) 0.75
Binding of pro-migratory serum factors to electrospun PLLA nano-fibers. J Biomater Sci Polym Ed (2013) 0.75
Evaluation of the stromal vascular fraction of adipose tissue as the basis for a stem cell-based tissue-engineered vascular graft. J Vasc Surg (2016) 0.75
Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells. Expert Opin Biol Ther (2015) 0.75
Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration. Stem Cell Res Ther (2017) 0.75
End-Point Immobilization of Heparin on Plasma-Treated Surface of Electrospun Polycarbonate-Urethane Vascular Graft. Acta Biomater (2017) 0.75
The combination of stem cells and tissue engineering: an advanced strategy for blood vessels regeneration and vascular disease treatment. Stem Cell Res Ther (2017) 0.75
Degradation and erosion mechanisms of bioresorbable porous acellular vascular grafts: an in vitro investigation. J R Soc Interface (2017) 0.75
Functional arteries grown in vitro. Science (1999) 6.08
A completely biological tissue-engineered human blood vessel. FASEB J (1998) 5.82
Human mesenchymal stem cells modulate B-cell functions. Blood (2005) 5.12
Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells (2002) 4.62
Electrospinning of collagen nanofibers. Biomacromolecules (2002) 4.51
A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials (2003) 3.63
A blood vessel model constructed from collagen and cultured vascular cells. Science (1986) 3.36
Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med (2001) 3.24
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation (2003) 2.49
Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng (2000) 2.33
Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett (2006) 2.00
Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem (2004) 1.96
Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. Tissue Eng (2004) 1.58
Engineered collagen-PEO nanofibers and fabrics. J Biomater Sci Polym Ed (2001) 1.39
Electrospinning of poly(ethylene-co-vinyl alcohol) fibers. Biomaterials (2003) 1.31
A hybrid vascular model biomimicking the hierarchic structure of arterial wall: neointimal stability and neoarterial regeneration process under arterial circulation. J Thorac Cardiovasc Surg (1995) 0.87
Genome sequence of Aedes aegypti, a major arbovirus vector. Science (2007) 9.19
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst (2006) 6.73
MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell (2010) 3.18
Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke (2006) 2.68
Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J (2002) 2.46
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology (2007) 2.43
Anisotropic mechanosensing by mesenchymal stem cells. Proc Natl Acad Sci U S A (2006) 2.43
Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke (2008) 2.32
Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells. Int J Cancer (2004) 2.31
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol (2011) 2.19
Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke (2003) 2.07
Boolean network simulations for life scientists. Source Code Biol Med (2008) 2.05
Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells. Biotechnol Bioeng (2004) 2.05
Temporal lobe arteriovenous malformations: anatomical subtypes, surgical strategy, and outcomes. J Neurosurg (2013) 2.02
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer (2009) 2.01
A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery (2010) 2.01
Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett (2006) 2.00
Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol (2010) 1.96
Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem (2004) 1.96
The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β. Biomaterials (2011) 1.93
CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke (2012) 1.91
Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release (2004) 1.90
Critical roles of macrophages in the formation of intracranial aneurysm. Stroke (2010) 1.85
Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res (2006) 1.81
Bioactive nanofibers: synergistic effects of nanotopography and chemical signaling on cell guidance. Nano Lett (2007) 1.81
Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials (2005) 1.79
Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science (2010) 1.79
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
Rho mediates the shear-enhancement of endothelial cell migration and traction force generation. Biophys J (2004) 1.77
Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells (2010) 1.74
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Biology of vascular malformations of the brain. Stroke (2009) 1.70
Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery (2008) 1.69
Functional electrospun nanofibrous scaffolds for biomedical applications. Adv Drug Deliv Rev (2007) 1.69
Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis (2012) 1.68
Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun (2012) 1.66
Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg (2006) 1.66
Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66
Regulation of vascular smooth muscle cells by micropatterning. Biochem Biophys Res Commun (2003) 1.63
Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke (2005) 1.61
Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol (2011) 1.55
Biophysical regulation of epigenetic state and cell reprogramming. Nat Mater (2013) 1.55
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53
"Tangential" resection of medial temporal lobe arteriovenous malformations with the orbitozygomatic approach. Neurosurgery (2004) 1.53
Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology. Stroke (2011) 1.53
Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neurosci Lett (2013) 1.52
Electrocautery interference with intraoperative electrocardiogram mimicking ST-segment depression. J Electrocardiol (2009) 1.52
Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol (2006) 1.51
Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun (2005) 1.50
Correlation between lumenal geometry changes and hemodynamics in fusiform intracranial aneurysms. AJNR Am J Neuroradiol (2005) 1.50
Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci (2002) 1.49
Computational approach to quantifying hemodynamic forces in giant cerebral aneurysms. AJNR Am J Neuroradiol (2003) 1.49
Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol (2006) 1.48
Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng (2006) 1.46
Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab (2004) 1.44
Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke (2009) 1.44
PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc Natl Acad Sci U S A (2004) 1.42
Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab (2007) 1.39
Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke (2004) 1.39
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. Stroke (2007) 1.38
Control of degradation rate and hydrophilicity in electrospun non-woven poly(D,L-lactide) nanofiber scaffolds for biomedical applications. Biomaterials (2003) 1.36
Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J Clin Invest (2008) 1.33
Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study. Arterioscler Thromb Vasc Biol (2012) 1.33
Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke (2004) 1.33
Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm. Acta Neurochir Suppl (2011) 1.32
Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous poly(lactide-co-glycolide)-based membranes. Ann Surg (2004) 1.30
Phase-contrast magnetic resonance imaging measurements in intracranial aneurysms in vivo of flow patterns, velocity fields, and wall shear stress: comparison with computational fluid dynamics. Magn Reson Med (2009) 1.26
Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery (2005) 1.26
Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery (2004) 1.26
Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development. Stroke (2008) 1.25
Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. Am J Physiol Heart Circ Physiol (2008) 1.24
Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci (2002) 1.24
MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed) (2011) 1.24
MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci (2006) 1.24